Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial

Autor: Ghaneh, Paula *, Palmer, Daniel, Cicconi, Silvia, Jackson, Richard, Halloran, Christopher Michael, Rawcliffe, Charlotte, Sripadam, Rajaram, Mukherjee, Somnath, Soonawalla, Zahir, Wadsley, Jonathan, Al-Mukhtar, Ahmed, Dickson, Euan, Graham, Janet, Jiao, Long, Wasan, Harpreet S, Tait, Iain S, Prachalias, Andreas, Ross, Paul, Valle, Juan W, O'Reilly, Derek A, Al-Sarireh, Bilal, Gwynne, Sarah, Ahmed, Irfan, Connolly, Kate, Yim, Kein-Long, Cunningham, David, Armstrong, Thomas, Archer, Caroline, Roberts, Keith, Ma, Yuk Ting, Springfeld, Christoph, Tjaden, Christine, Hackert, Thilo, Büchler, Markus W, Neoptolemos, John P
Zdroj: In The Lancet Gastroenterology & Hepatology February 2023 8(2):157-168
Databáze: ScienceDirect